推荐产品
品質等級
化驗
80%
形狀
liquid
燃燒殘留物
≤0.1% (as SO4)
溶解度
water: soluble(lit.)
負離子痕跡
chloride (Cl-): ≤50 mg/kg
sulfate (SO42-): ≤100 mg/kg
正離子痕跡
Ca: ≤100 mg/kg
Fe: ≤10 mg/kg
抗生素活性譜
Gram-negative bacteria
作用方式
cell membrane | interferes
SMILES 字串
C[C@H](O)C(O)=O
InChI
1S/C3H6O3/c1-2(4)3(5)6/h2,4H,1H3,(H,5,6)/t2-/m0/s1
InChI 密鑰
JVTAAEKCZFNVCJ-REOHCLBHSA-N
正在寻找类似产品? 访问 产品对比指南
相关类别
應用
- Pharmaceutical and biomaterial applications: L-(+)-Lactic acid enhances M2 macrophage polarization through regulation of the PCK2/AMPK/mTOR signaling pathway in poly-L-lactic acid membranes, indicating its vital role in biomedicine and materials science (Tang et al., 2024).
- Agricultural biotechnology: The induction of defense responses in tobacco against Phytophthora nicotianae by L-(+)-Lactic acid underscores its potential application in agricultural biotechnology for plant disease management (Yan et al., 2024).
生化/生理作用
用作乳酸脱氢酶的底物。
訊號詞
Danger
危險聲明
危險分類
Eye Dam. 1 - Skin Corr. 1
安全危害
儲存類別代碼
8A - Combustible corrosive hazardous materials
水污染物質分類(WGK)
WGK 1
閃點(°F)
230.0 °F
閃點(°C)
110 °C
個人防護裝備
Faceshields, Gloves, Goggles, type ABEK (EN14387) respirator filter
其他客户在看
Synthesis and characterization of pH-sensitive hydrogels based on chitosan and D, L-lactic acid.
Journal of Applied Polymer Science, 74(13), 3193-3202 (1999)
Swelling and hydrolytic degradation of poly (D, L-lactic acid) in aqueous solutions.
Polymer Degradation and Stability, 91(3), 614-619 (2006)
Proceedings of the National Academy of Sciences of the United States of America, 114(11), 2934-2939 (2017-03-02)
The genetic and phenotypic diversity of cells within tumors is a major obstacle for cancer treatment. Because of the stochastic nature of genetic alterations, this intratumoral heterogeneity is often viewed as chaotic. Here we show that the altered metabolism of
Recovery of L-(+)-lactic acid by anion exchange resin Amberlite IRA-400.
Biochemical Engineering Journal, 11(2), 189-196 (2002)
BJU international, 88(1), 30-34 (2001-07-12)
To assess whether patients in acute urinary retention from benign prostatic enlargement can be treated with a combined therapy comprising finasteride and a bioabsorbable self-reinforced poly L-lactic acid (SR-PLLA) urethral stent. Fifty-five patients in acute urinary retention were treated as
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门